Evidence map›Paper›PMID 28279949›Full record

ArticleJMIR mHealth and uHealth2017

Usability and Acceptability of a Mobile Comprehensive HIV Prevention App for Men Who Have Sex With Men: A Pilot Study.

Patrick S Sullivan, Robert Driggers, Joanne D Stekler, Aaron Siegler, Tamar Goldenberg, Sarah J McDougal, Jason Caucutt, Jeb Jones, Rob Stephenson

Registry-linked trialAbstract read
In one paragraph

Article in JMIR mHealth and uHealth, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05325476 (Testing of the JomPrEP App for HIV Prevention Among Malaysian MSM), which is not on this map. Cited by 103 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 9 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05325476 nacompletednot on this mapstarted 2023, after this paper: background citation

Testing of the JomPrEP App for HIV Prevention Among Malaysian MSM

TypeinterventionalSponsorUniversity of ConnecticutRan2023 to 2025Enrolled268ConditionsHIV Prevention ProgramArmsJomPrEP App, Inactivated JomPrEP app
3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 9 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Patrick S SullivanRollins School of Public Health, Department of Epidemiology, Emory University, Atlanta, GA, United States.ORCID http://orcid.org/0000-0002-7728-0587
Robert DriggersRollins School of Public Health, Department of Epidemiology, Emory University, Atlanta, GA, United States.ORCID http://orcid.org/0000-0002-2073-4242
Joanne D SteklerDepartment of Medicine, University of Washington, Seattle, WA, United States.ORCID http://orcid.org/0000-0001-8064-3011
Aaron SieglerRollins School of Public Health, Department of Epidemiology, Emory University, Atlanta, GA, United States.ORCID http://orcid.org/0000-0001-5553-7540
Tamar GoldenbergCenter for Sexuality and Health Disparities, School of Nursing, University of Michigan, Ann Arbor, MI, United States.ORCID http://orcid.org/0000-0003-3998-2913
Sarah J McDougalDepartment of Medicine, Department of Medicine, University of Washington, Seattle, WA, United States.ORCID http://orcid.org/0000-0001-7690-7002
Jason CaucuttDepartment of Medicine, University of Washington, Seattle, WA, United States.ORCID http://orcid.org/0000-0001-6590-9248
Jeb JonesRollins School of Public Health, Department of Epidemiology, Emory University, Atlanta, GA, United States.ORCID http://orcid.org/0000-0001-9165-1658
Rob StephensonCenter for Sexuality and Health Disparities, School of Nursing, University of Michigan, Ann Arbor, MI, United States.ORCID http://orcid.org/0000-0002-9239-2640

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Carlos del Rio · 2002 to 2026
$74.0M
NIAID NIH HHS P30 AI050409
6 · The paper itself

Abstract

backgroundMen who have sex with men (MSM) are the group most impacted by the human immunodeficiency virus (HIV) epidemic and the only subgroup in the United States among which new HIV diagnoses are not decreasing. To achieve the US National HIV/AIDS (acquired immunodeficiency syndrome) Strategy goals of reducing new diagnoses by 25%, high (eg, 30-50%) coverage of multiple HIV prevention interventions is needed in both urban and rural areas. Mobile phone "apps" are an important channel through which prevention services could be provided at scale and at low marginal cost.

objectiveThe aim of this study was to evaluate the usability and acceptability of a theory-based Android mobile phone app for HIV prevention.

methodsThe app included self-assessment tools; prevention recommendations; commodity (condoms, HIV self-tests) ordering; reminders to MSM for basic HIV prevention services, HIV testing, condom use, screening for preexposure prophylaxis (PrEP) and nonoccupational postexposure prophylaxis (nPEP); and prevention and treatment provider locators. The study recruited HIV-negative, Android-using MSM in Atlanta and Seattle who were asked to use the app for 4 months and complete a post-use survey. We measured the use of the app and its features, ordering of commodities, self-report of establishing an HIV testing plan, being HIV tested in the community, and starting PrEP or using nPEP. Usability was assessed using the system usability scale (SUS).

resultsA total of 121 MSM were enrolled (59.5%, 72/121 from Atlanta; 40.5%, 49/121 from Seattle). Median age was 28. Nearly half (48.8%, 59/121) were nonwhite, and most (85.9%, 104/121) were gay-identified. Most had tested for HIV in the past (85.1%, 103/121), and 52 (43.0%, 52/121) had a plan to test for HIV regularly. Men used the app for an average of 17.7 minutes over the first 4 months. Over the 4-month period, over half ordered condoms (63.6%, 77/121) and HIV test kits (52.8%, 64/121) on the app. Eight of 86 (9%) PrEP-eligible MSM started PrEP during the 4-month period; of those, 6 of the 8 reported that the app influenced their decision to start PrEP. The mean SUS was 73 (above average).

conclusionsA theory-based mobile phone app was acceptable to MSM and was rated as having above-average usability. Most men used the commodity-ordering features of the app during the 4-month evaluation period, and nearly 1 in 10 PrEP-eligible men started PrEP, with most attributing their decision to start PrEP in part to the app. A broader, randomized controlled study of the impact of the app on uptake of prevention behaviors for MSM is warranted.

Indexed as

condomshomosexuality, malemobile applicationspilot projectspre-exposure prophylaxissexual minorities

Identifiers

PMID28279949
PMCPMC5364322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.